title: Expectations of response from octreotide therapy in recurrent phosphaturic mesenchymal tumors--do they reflect reality?
authors.affiliation: Ankara Ataturk Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey E-mail : drarifeulas@hotmail.com.
authors.forename: Arife
authors.initials: A
authors.lastname: Ulas
authors.forename: Didem Sener
authors.initials: DS
authors.lastname: Dede
authors.forename: Mehmet Ali Nahit
authors.initials: MA
authors.lastname: Sendur
authors.forename: Muhammed Bulent
authors.initials: MB
authors.lastname: Akinci
authors.forename: Bulent
authors.initials: B
authors.lastname: Yalcin
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D007015:Hypophosphatemia, Familial / Q000188:drug therapy*; D008637:Mesenchymoma / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D015282:Octreotide / Q000627:therapeutic use*; D011379:Prognosis
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide